SGA
DPLO

Siguler Guff Advisers’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Siguler Guff Advisers’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-37,814
Closed -$1.04M – 5
2016
Q1 		$1.04M Hold
37,814
– – 2.01% 4
2015
Q4 		$1.29M Buy
+37,814
New +$1.18M 2.4% 4

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Siguler Guff Advisers's DPLO Position: Q2 2016 in Review

Siguler Guff Advisers sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2016, closing a stake of 37,814 shares — an estimated $1.04M sold.

Siguler Guff Advisers first reported a position in DPLO in Q4 2015 and held it in 2 quarters. The position peaked at $1.29M in Q4 2015. 166 funds tracked by Wall St. Rank hold DPLO as of Q2 2016.

  • Siguler Guff Advisers reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2016 after selling out during the quarter.
  • Siguler Guff Advisers sold 37,814 DIPLOMAT PHARMACY, INC. shares in Q2 2016, an estimated $1.04M.
  • Siguler Guff Advisers first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 2 quarters.
  • Siguler Guff Advisers's DIPLOMAT PHARMACY, INC. position peaked at $1.29M in Q4 2015.
  • 166 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2016.

Based on Siguler Guff Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.